Keyphrases
Bone Turnover
100%
Bisphosphonates
59%
Bone Mineral Density
57%
Osteoporosis Treatment
55%
Bone Disorders
50%
Undercarboxylated Osteocalcin
50%
Official Positions
50%
Osteopenia
50%
Bone Metabolism
50%
Phosphate Metabolism
50%
Hypercalcemia
50%
Estrogen Status
50%
Osteoporosis Diagnosis
50%
Paget's Disease of Bone
50%
Vitamin K2
50%
MK-4
50%
Vertebral Fracture Assessment
50%
Menaquinone-4
50%
Bone Disease
50%
Menopause
50%
Hypocalcemia
50%
Cortical Fracture
50%
Disseminated Tumor Cells
50%
Zoledronic Acid
50%
Phase II Trial
50%
Maximum Tolerated Dose
50%
Locally Advanced Breast Cancer
50%
Vertebral Fracture
50%
Osteoporosis
50%
Randomized Phase II Trial
50%
Nitrogen-containing Bisphosphonates
50%
Dose-response
50%
Matching Rate
50%
Bone Biopsy
50%
Low Energy
50%
Surgical Skills
50%
Alendronate
32%
Osteoporotic Fractures
23%
Bone Marrow
19%
Atypical Femur Fracture
18%
Osteonecrosis of the Jaw
18%
Postmenopausal Women
16%
Acid Groups
15%
Spine Imaging
12%
Low Radiation
12%
Classification Strategy
12%
Historical Height Loss
12%
Quality of Life
12%
Prednisone
12%
Glucocorticoid Therapy
12%
Medicine and Dentistry
Bone Turnover
75%
Bisphosphonate
53%
Spine Fracture
50%
Locally Advanced Breast Cancer
50%
Metastatic Carcinoma
50%
Bone Biopsy
50%
Zoledronic Acid
50%
Bone Disease
50%
Surgery
50%
Bone Density
32%
Bone Remodeling
32%
Osteoporosis
25%
Hypocalcaemia
25%
Paget Bone Disease
25%
Osteopenia
25%
Hypercalcaemia
25%
Phosphate Metabolism
25%
Diseases
25%
Ophthalmology
16%
Urology
16%
General Surgery
16%
Otorhinolaryngology
16%
Neurosurgery
16%
Orthopedic Surgery
16%
Breast Cancer
11%
Disease Exacerbation
7%
Docetaxel
7%
Epirubicin
7%
Fragility Fracture
7%
Quality of Life
7%
Glucocorticoid
7%
Dual-Energy X-Ray Absorptiometry
7%
Diagnosis
7%
Health Care Cost
7%
Prednisone
7%
Clinical Feature
7%
Prevalence
7%
Femur Shaft Fracture
7%
Alendronic Acid
7%
Osteoplasty
7%
Tetracycline
7%
Pelvis
7%
Rib
7%
